2021-01-05,Mustang Bio to Participate in Three January 2021 Virtual Investor Conferences
2020-12-22,"These 2 Penny Stocks Are Poised for a Massive Rally, Say Analysts"
2020-12-21,Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13R2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors
2020-12-18,"Non-Executive Director Lindsay Rosenwald Just Bought 100% More Shares In Mustang Bio, Inc. (NASDAQ:MBIO)"
2020-12-14,Is MBIO A Good Stock To Buy Now?
2020-12-07,Mustang Bio Announces Interim Phase 1/2 Data for MB-106 in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
2020-12-04,Is the Options Market Predicting a Spike in Mustang Bio (MBIO) Stock?
2020-12-01,Mustang Bio to Host Key Opinion Leader Call on MB-106 for the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
2020-11-24,Mustang Bio Announces Positive Opinion from the European Medicines Agency on Orphan Drug Designation for Its Lentiviral Gene Therapy for the Treatment of X-linked Severe Combined Immunodeficiency (XSCID)
2020-11-23,Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP Manufacturing Agreement for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
2020-11-09,Will Mustang Bio (NASDAQ:MBIO) Spend Its Cash Wisely?
2020-11-06,Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
2020-11-04,Mustang Bio Announces MB-106 Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
2020-10-26,Mustang Bio Announces Initial Phase 1 Data on MB-105 for Patients with PSCA-positive Castration Resistant Prostate Cancer
2020-10-08,Mustang Bio Announces MB-105 Data Selected for Presentation at the Virtual 27th Annual Prostate Cancer Foundation Scientific Retreat
2020-10-07,Horizon Technology Finance Provides Third Quarter 2020 Portfolio Update
2020-10-06,Mustang Bio Licenses LentiBOOST Technology from SIRION Biotech
2020-10-01,Mustang Bio Announces First Patient Dosed in Multicenter Phase 1/2 Clinical Trial of MB-102 (CD123-targeted CAR T Cell Therapy)
2020-09-22,Mustang Bio Announces Orphan Drug Designation for MB-207 for the Treatment of X-linked Severe Combined Immunodeficiency (XSCID) in Previously Transplanted Patients
2020-09-18,Is the Options Market Predicting a Spike in Mustang Bio (MBIO) Stock?
2020-09-10,Mustang Bio to Participate in Three September 2020 Virtual Investor Conferences
2020-09-02,Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
2020-08-31,Mustang Bio Announces Rare Pediatric Disease Designation for MB-207 for the Treatment of X-linked Severe Combined Immunodeficiency in Previously Transplanted Patients
2020-08-24,"What You Need To Know About Mustang Bio, Inc.'s (NASDAQ:MBIO) Investor Composition"
2020-08-18,Do Options Traders Know Something About Mustang Bio (MBIO) Stock We Don't?
2020-08-17,Mustang Bio to Present at the Virtual Fortress Biotech Corporate Access Summit
2020-08-17,Mustang Bio Announces Rare Pediatric Disease Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency
2020-08-12,Oppenheimer: These 3 Penny Stocks Could Rally Over 100%
2020-08-10,Mustang Bio Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
2020-07-21,Mustang Bio (MBIO) Looks Good: Stock Adds 5.8% in Session
2020-06-25,"Hedge Funds Have Never Been This Bullish On Mustang Bio, Inc. (MBIO)"
2020-06-17,Do Options Traders Know Something About Mustang Bio (MBIO) Stock We Don't?
2020-06-11,Mustang Bio Announces Pricing of Public Offering of Common Stock
2020-06-11,Mustang Bio (MBIO) Jumps: Stock Rises 8.2%
2020-06-10,Mustang Bio Announces Proposed Public Offering of Common Stock
2020-06-04,Mustang Bio to Host Virtual Annual Meeting of Stockholders
2020-05-25,"Trade Alert: The President Of Mustang Bio, Inc. (NASDAQ:MBIO), Manuel Litchman, Has Just Spent US$533k Buying 545% More Shares"
2020-05-21,Is Mustang (MBIO) Stock a Solid Choice Right Now?
2020-05-12,Mustang Bio Announces Presentations at 23rd Annual Meeting of the American Society of Gene & Cell Therapy
2020-05-11,Mustang Bio Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
2020-04-20,Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
2020-04-07,"Before You Buy Mustang Bio, Inc. (NASDAQ:MBIO), Consider Its Volatility"
2020-03-16,Mustang Bio Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
2020-03-15,3 Stocks That Should Bounce Back Once Coronavirus Fears Fade
2020-02-18,Mustang Bio Announces First Subject Treated in Phase 1/2 Trial with the Optimized CD20-targeted CAR T Cell Therapy MB-106
2020-01-22,Mustang Bio to Present at the Phacilitate Leaders World & World Stem Cell Summit 2020
2019-12-27,"Mustang Bio, Inc. (MBIO) Upgraded to Buy: What Does It Mean for the Stock?"
2019-12-20,"Hedge Funds Are Done Buying Mustang Bio, Inc. (MBIO)"
2019-12-09,Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency
2019-12-02,Mustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx Conference
2019-11-12,Mustang Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
2019-11-06,Mustang Bio Announces MB-107 Lentiviral Gene Therapy and MB-106 CD20-Targeted CAR T Data Selected for Presentations at 61st American Society of Hematology Annual Meeting
2019-10-24,Mustang Bio Announces Dosing of First Participant in Phase 1 Clinical Trial of MB-108 (Oncolytic Virus C134) to Treat Glioblastoma
2019-10-10,Mustang Bio Announces City of Hope Receives $4.1 Million in Grant Awards for Recently Opened First-of-Its-Kind Clinical Trial for Patients with Recurrent Malignant Glioma
2019-10-08,"Have Insiders Been Buying Mustang Bio, Inc. (NASDAQ:MBIO) Shares This Year?"
2019-09-26,Mustang Bio to Participate in October 2019 Investor Conferences
2019-09-23,Mustang Bio Announces Phase 1 Clinical Trial Evaluating MB-105 for Prostate Stem Cell Antigen-Positive Castration-Resistant Prostate Cancer Enrolling Patients at City of Hope
2019-09-09,Mustang Bio to Present at Scientific Conferences in September 2019
2019-09-03,Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution
2019-08-29,Mustang Bio to Present at September 2019 Investor Conferences
2019-08-27,Mustang Bio Announces License Agreement with CSL Behring for the Cytegrity Stable Producer Cell Line for the Production of MB-107 Lentiviral Gene Therapy
2019-08-22,Mustang Bio and St. Jude Childrens Research Hospital announce MB-107 lentiviral gene therapy for X-linked Severe Combined Immunodeficiency (XSCID) granted regenerative medicine advanced therapy (RMAT) designation from FDA
2019-08-13,Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain Metastases
2019-08-12,Mustang Bio to Present at 11th Annual Bioprocessing Summit
2019-08-09,Mustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
2019-08-05,FDA Clears IND for Mustang Bios MB-102 (CD123 CAR T)
2019-07-24,Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia
2019-07-10,The Mustang Bio (NASDAQ:MBIO) Share Price Is Down 52% So Some Shareholders Are Wishing They Sold
2019-05-23,Mustang Bio and St. Jude Childrens Research Hospital to Participate in Panel Discussion at Boston CEO 2019
2019-05-16,Mustang Bio and Nationwide Childrens Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma
2019-05-13,Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019
2019-05-10,Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
2019-05-08,Mustang Bio Announces Full Exercise of Option
2019-05-08,Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
2019-04-30,Mustang Bio Announces Pricing of Public Offering of Common Stock
2019-04-30,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering"
2019-04-29,Mustang Bio Announces Proposed Public Offering of Common Stock
2019-04-29,FDA Events Put Healthcare Stocks In The Headlines: Here's One That No One's Talking About Yet
2019-04-23,Is Mustang Bio the Next Great Biotech Stock?
2019-04-18,Mustang Bio News: MBIO Stock Skyrockets on New Bubble Boy Therapy
2019-04-18,Why Mustang Bio Stock Is On Fire Today
2019-04-18,Bubble Boy Biotech Soars 250 Percent After Cure Announcement
2019-04-18,"The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio"
2019-04-18,Mustang Bio's stock soars to near 4-fold gain after deal to commercialize 'bubble boy' disease treatment
2019-04-18,Behind the licensing deal for St. Jude's 'bubble boy' disease cure
2019-04-17,"Stocks to watch: Unilever, Moneysupermarket, Mustang Bio, Indivior"
2019-04-17,St. Jude Childrens Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine
2019-04-17,St. Jude develops cure for bubble boy disease
2019-04-09,Mustang Bio to Present at the World Orphan Drug Congress USA 2019
2019-04-01,Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance
2019-03-18,Mustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
2019-03-13,Mustang Bio to Present at Oppenheimers 29th Annual Healthcare Conference
2019-02-20,Mustang Bio and Nationwide Childrens Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme
2018-12-20,"Need To Know: Mustang Bio, Inc. (NASDAQ:MBIO) Insiders Have Been Buying Shares"
2018-12-20,Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
2018-12-17,MBIO: Mustang: A Steed on the Fast Track
2018-11-28,Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy
2018-11-19,"Investor Expectations to Drive Momentum within Lawson Products, Kingold Jewelry, Liberty Broadband, Mustang Bio, Artesian Resources, and MYnd Analytics  Discovering Underlying Factors of Influence"
2018-11-13,Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
2018-10-30,Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope
